Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
545 | 13948 | 32.4 | 61% |
Classes in level above (level 3) |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | REBAMIPIDE | Author keyword | 187 | 73% | 1% | 141 |
2 | GASTRIC MUCOSAL BLOOD FLOW | Author keyword | 104 | 67% | 1% | 93 |
3 | GASTRIC MUCOSA | Author keyword | 104 | 33% | 2% | 257 |
4 | GASTROPROTECTION | Author keyword | 101 | 50% | 1% | 147 |
5 | ENTEROCHROMAFFIN LIKE CELLS | Author keyword | 99 | 77% | 0% | 67 |
6 | PENTADECAPEPTIDE BPC 157 | Author keyword | 94 | 94% | 0% | 33 |
7 | GASTRIC ULCER | Author keyword | 93 | 26% | 2% | 315 |
8 | ECL CELL | Author keyword | 91 | 89% | 0% | 41 |
9 | ENTEROCHROMAFFIN LIKE CELL | Author keyword | 90 | 80% | 0% | 56 |
10 | ACID SECRETION | Author keyword | 80 | 40% | 1% | 158 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | REBAMIPIDE | 187 | 73% | 1% | 141 | Search REBAMIPIDE | Search REBAMIPIDE |
2 | GASTRIC MUCOSAL BLOOD FLOW | 104 | 67% | 1% | 93 | Search GASTRIC+MUCOSAL+BLOOD+FLOW | Search GASTRIC+MUCOSAL+BLOOD+FLOW |
3 | GASTRIC MUCOSA | 104 | 33% | 2% | 257 | Search GASTRIC+MUCOSA | Search GASTRIC+MUCOSA |
4 | GASTROPROTECTION | 101 | 50% | 1% | 147 | Search GASTROPROTECTION | Search GASTROPROTECTION |
5 | ENTEROCHROMAFFIN LIKE CELLS | 99 | 77% | 0% | 67 | Search ENTEROCHROMAFFIN+LIKE+CELLS | Search ENTEROCHROMAFFIN+LIKE+CELLS |
6 | PENTADECAPEPTIDE BPC 157 | 94 | 94% | 0% | 33 | Search PENTADECAPEPTIDE+BPC+157 | Search PENTADECAPEPTIDE+BPC+157 |
7 | GASTRIC ULCER | 93 | 26% | 2% | 315 | Search GASTRIC+ULCER | Search GASTRIC+ULCER |
8 | ECL CELL | 91 | 89% | 0% | 41 | Search ECL+CELL | Search ECL+CELL |
9 | ENTEROCHROMAFFIN LIKE CELL | 90 | 80% | 0% | 56 | Search ENTEROCHROMAFFIN+LIKE+CELL | Search ENTEROCHROMAFFIN+LIKE+CELL |
10 | ACID SECRETION | 80 | 40% | 1% | 158 | Search ACID+SECRETION | Search ACID+SECRETION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ENTEROCHROMAFFIN LIKE CELLS | 264 | 66% | 2% | 246 |
2 | ACID SECRETION | 246 | 30% | 5% | 680 |
3 | RAT STOMACH | 185 | 49% | 2% | 276 |
4 | CYTOPROTECTION | 180 | 50% | 2% | 260 |
5 | BPC 157 | 151 | 95% | 0% | 52 |
6 | ALKALINE SECRETION | 148 | 78% | 1% | 97 |
7 | OXYNTIC MUCOSA | 135 | 81% | 1% | 81 |
8 | PARIETAL CELLS | 130 | 38% | 2% | 268 |
9 | ADAPTIVE CYTOPROTECTION | 118 | 81% | 1% | 70 |
10 | LUMINAL ACID | 117 | 89% | 0% | 54 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
NSAID-Induced Small Intestinal Damage - Roles of Various Pathogenic Factors | 2015 | 1 | 67 | 78% |
Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach | 2015 | 1 | 61 | 51% |
Present status and strategy of NSAIDs-induced small bowel injury | 2009 | 79 | 67 | 78% |
Gastric mucosal defense and cytoprotection: Bench to bedside | 2008 | 202 | 167 | 42% |
Prostaglandins, NSAIDs, and gastric mucosal protection: Why doesn't the stomach digest itself? | 2008 | 158 | 200 | 52% |
Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years | 1997 | 399 | 138 | 45% |
SIDE-EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON THE SMALL AND LARGE-INTESTINE IN HUMANS | 1993 | 572 | 129 | 49% |
Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin | 2005 | 176 | 220 | 65% |
The regulation of gastric acid secretion - clinical perspectives | 2014 | 9 | 114 | 64% |
GASTRODUODENAL MUCOSAL PROTECTION | 1993 | 306 | 262 | 83% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KYOTO GASTROINTESTINAL DIS | 12 | 86% | 0.0% | 6 |
2 | GASTROENTEROL SECT 111G | 9 | 47% | 0.1% | 14 |
3 | INTRAABDOMINAL DIS | 9 | 55% | 0.1% | 11 |
4 | DRUG EVALUAT TOXICOL SCI | 8 | 75% | 0.0% | 6 |
5 | BIODEF MED | 7 | 48% | 0.1% | 11 |
6 | ULCER EDUC | 7 | 25% | 0.2% | 25 |
7 | GREATER LOS ANGELES VET AFFAIRS HEALTHCARE SYST | 7 | 38% | 0.1% | 14 |
8 | CLIN HOSP DR M STOJANOVIC | 6 | 100% | 0.0% | 4 |
9 | BIOL SAUDE PUBL | 5 | 63% | 0.0% | 5 |
10 | GASTROENTEROL 111G | 5 | 63% | 0.0% | 5 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000016394 | HISTAMINE H 3 RECEPTOR//THIOPERAMIDE//HISTAMINE |
2 | 0.0000013032 | PERFORATED PEPTIC ULCER//PEPTIC ULCER PERFORATION//HIGHLY SELECTIVE VAGOTOMY |
3 | 0.0000011100 | NSAIDS//NABUMETONE//ROFECOXIB |
4 | 0.0000010899 | CHOLECYSTOKININ//L 365 260//GASTRIN |
5 | 0.0000010211 | SUCRASE ISOMALTASE//CDX2//EPIMORPHIN |
6 | 0.0000008529 | HELICOBACTER PYLORI//HELICOBACTER//CAGA |
7 | 0.0000006799 | MUC1//MUCIN//MUC5AC |
8 | 0.0000006484 | NEUROENDOCRINE TUMORS//CARCINOID//GASTRINOMA |
9 | 0.0000005464 | GASTROESOPHAGEAL REFLUX DISEASE//GASTROESOPHAGEAL REFLUX//ACHALASIA |
10 | 0.0000005316 | IRRITABLE BOWEL SYNDROME//NEUROGASTROENTEROLOGY AND MOTILITY//FUNCTIONAL DYSPEPSIA |